Literature DB >> 17926640

Altered expression of nucleoside transporter genes (SLC28 and SLC29) in adipose tissue from HIV-1-infected patients.

Jordi P Guallar1, Pedro Cano-Soldado, Ivette Aymerich, Joan C Domingo, Marta Alegre, Pere Domingo, Francesc Villarroya, F Javier Casado, Marta Giralt, Marçal Pastor-Anglada.   

Abstract

BACKGROUND: Nucleoside transporter proteins (NTs) encoded by members of the SLC28 and SLC29 gene families contribute to nucleoside and nucleobase recycling but also modulate extracellular adenosine levels and thus adenosine-regulated metabolic targets.
METHODS: We have examined the expression pattern of NT-encoding genes in human adipose tissue and we have further analysed whether the mRNA related to these genes show changes in their amounts associated with either HIV-1 infection, highly active antiretroviral therapy (HAART) or development of HIV-1-associated lipodystrophy syndrome (HALS).
RESULTS: Human adipocytes express SLC28A1, SLC28A2 and SLC28A3 (encoding hCNT1, hCNT2 and hCNT3, respectively) and SLC29A1 and SLC29A2 (encoding hENT1 and hENT2, respectively). HIV-1 infection, prior to HAART and HALS development, is associated with the upregulation of the mRNA levels of the genes encoding hCNT1, hCNT3 and hENT2. The increase in the mRNA amounts for the former two genes may be due to the action of tumour necrosis factor-alpha (TNF-alpha), a cytokine with enhanced expression in adipose tissue following HIV-1 infection, as the effect is also observed in human adipocytes in culture after treatment with TNF-alpha. HAART and HALS development are associated with the upregulation of the mRNA levels encoding hCNT2 and hENT1, and further enhancement of hCNT1, hCNT3 and hENT2 gene expression.
CONCLUSIONS: These data suggest that selected genes of the SLC28 and SLC29 families are not only targets of HIV-1 infection, but might also contribute to the development of adipose tissue alterations leading to lipodystrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926640

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  10 in total

Review 1.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

Review 2.  HIV Persistence in Adipose Tissue Reservoirs.

Authors:  Jacob Couturier; Dorothy E Lewis
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 3.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

4.  Vaginal ecosystem modeling of growth patterns of anaerobic bacteria in microaerophilic conditions.

Authors:  Audrie A Medina-Colorado; Kathleen L Vincent; Aaron L Miller; Carrie A Maxwell; Lauren N Dawson; Trevelyn Olive; Elena V Kozlova; Marc M Baum; Richard B Pyles
Journal:  Anaerobe       Date:  2017-04-26       Impact factor: 3.331

5.  The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.

Authors:  Omar Janneh; Andrew Owen; Patrick G Bray; David J Back; Munir Pirmohamed
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

6.  Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.

Authors:  Pere Domingo; Javier Torres-Torronteras; Virginia Pomar; Marta Giralt; Joan Carles Domingo; Maria Del Mar Gutierrez; José M Gallego-Escuredo; Maria Gracia Mateo; Pedro Cano-Soldado; Irene Fernandez; Marçal Pastor-Anglada; Francesc Vidal; Francesc Villarroya; Antoni Andreu; Ramon Marti
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

7.  Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition.

Authors:  S Selvaraj; M Ghebremichael; M Li; Y Foli; A Langs-Barlow; A Ogbuagu; L Barakat; E Tubridy; R Edifor; W Lam; Y-C Cheng; E Paintsil
Journal:  Clin Pharmacol Ther       Date:  2014-03-17       Impact factor: 6.875

8.  Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy.

Authors:  Pere Domingo; Maria del Carmen Cabeza; Ferran Torres; Juliana Salazar; Maria del Mar Gutierrez; Maria Gracia Mateo; Esteban Martínez; Joan Carles Domingo; Irene Fernandez; Francesc Villarroya; Esteban Ribera; Francesc Vidal; Montserrat Baiget
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients.

Authors:  Pere Domingo; Maria Gracia Mateo; Alain Pruvost; Ferran Torres; Juliana Salazar; Maria Del Mar Gutierrez; Joan Carles Domingo; Irene Fernandez; Francesc Villarroya; Francesc Vidal; Montserrat Baiget; Oscar de la Calle-Martín
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

Review 10.  Who Is Who in Adenosine Transport.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2018-06-14       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.